Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis.

Frankowski KJ, Wang C, Patnaik S, Schoenen FJ, Southall N, Li D, Teper Y, Sun W, Kandela I, Hu D, Dextras C, Knotts Z, Bian Y, Norton J, Titus S, Lewandowska MA, Wen Y, Farley KI, Griner LM, Sultan J, Meng Z, Zhou M, Vilimas T, Powers AS, Kozlov S, Nagashima K, Quadri HS, Fang M, Long C, Khanolkar O, Chen W, Kang J, Huang H, Chow E, Goldberg E, Feldman C, Xi R, Kim HR, Sahagian G, Baserga SJ, Mazar A, Ferrer M, Zheng W, Shilatifard A, Aubé J, Rudloff U, Marugan JJ, Huang S.

Sci Transl Med. 2018 May 16;10(441). pii: eaap8307. doi: 10.1126/scitranslmed.aap8307.

PMID:
29769289
2.

Potential Role of Methylation Marker in Glioma Supporting Clinical Decisions.

Roszkowski K, Furtak J, Zurawski B, Szylberg T, Lewandowska MA.

Int J Mol Sci. 2016 Nov 10;17(11). pii: E1876.

3.

Can chromatin conformation technologies bring light into human molecular pathology?

Kubiak M, Lewandowska MA.

Acta Biochim Pol. 2015;62(3):483-9. doi: 10.18388/abp.2015_984. Epub 2015 Sep 2. Review.

4.

High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.

Czubak K, Lewandowska MA, Klonowska K, Roszkowski K, Kowalewski J, Figlerowicz M, Kozlowski P.

Oncotarget. 2015 Sep 15;6(27):23399-416.

5.

Transdifferentiation of Bone Marrow Mesenchymal Stem Cells into the Islet-Like Cells: the Role of Extracellular Matrix Proteins.

Pokrywczynska M, Lewandowska MA, Krzyzanowska S, Jundzill A, Rasmus M, Warda K, Gagat M, Deptula A, Helmin-Basa A, Holysz M, Nowacki M, Buchholz L, Bodnar M, Marszalek A, Grzanka A, Jozwicki W, Michalkiewicz J, Drewa T.

Arch Immunol Ther Exp (Warsz). 2015 Oct;63(5):377-84. doi: 10.1007/s00005-015-0340-3. Epub 2015 May 10.

PMID:
25957583
6.

The use of a two-tiered testing strategy for the simultaneous detection of small EGFR mutations and EGFR amplification in lung cancer.

Lewandowska MA, Czubak K, Klonowska K, Jozwicki W, Kowalewski J, Kozlowski P.

PLoS One. 2015 Feb 26;10(2):e0117983. doi: 10.1371/journal.pone.0117983. eCollection 2015.

7.

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study.

Krawczyk P, Ramlau R, Chorostowska-Wynimko J, Powrózek T, Lewandowska MA, Limon J, Wasąg B, Pankowski J, Kozielski J, Kalinka-Warzocha E, Szczęsna A, Wojas-Krawczyk K, Skroński M, Dziadziuszko R, Jaguś P, Antoszewska E, Szumiło J, Jarosz B, Woźniak A, Jóźwicki W, Dyszkiewicz W, Pasieka-Lis M, Kowalski DM, Krzakowski M, Jassem J, Milanowski J.

J Cancer Res Clin Oncol. 2015 Jan;141(1):61-8. doi: 10.1007/s00432-014-1789-x. Epub 2014 Aug 3.

8.

Impact of specific KRAS mutation in exon 2 on clinical outcome of chemotherapy- and radiotherapy-treated colorectal adenocarcinoma patients.

Roszkowski K, Zurawski B, Jozwicki W, Basta P, Lewandowska MA.

Mol Diagn Ther. 2014 Oct;18(5):559-66. doi: 10.1007/s40291-014-0107-2.

9.

Prognostic and predictive biomarkers: tools in personalized oncology.

Nalejska E, Mączyńska E, Lewandowska MA.

Mol Diagn Ther. 2014 Jun;18(3):273-84. doi: 10.1007/s40291-013-0077-9. Review.

10.

The missing puzzle piece: splicing mutations.

Lewandowska MA.

Int J Clin Exp Pathol. 2013 Nov 15;6(12):2675-82. eCollection 2013. Review.

11.

An analysis of the prognostic value of IDH1 (isocitrate dehydrogenase 1) mutation in Polish glioma patients.

Lewandowska MA, Furtak J, Szylberg T, Roszkowski K, Windorbska W, Rytlewska J, Jóźwicki W.

Mol Diagn Ther. 2014 Feb;18(1):45-53. doi: 10.1007/s40291-013-0050-7.

12.

Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients.

Lewandowska MA, Jóźwicki W, Jochymski C, Kowalewski J.

Oncol Rep. 2013 Sep;30(3):1045-52. doi: 10.3892/or.2013.2579. Epub 2013 Jul 1.

13.

KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells.

Lewandowska MA, Jóźwicki W, Żurawski B.

Mol Diagn Ther. 2013 Jun;17(3):193-203. doi: 10.1007/s40291-013-0025-8.

14.

Tumor suppression by collagen XV is independent of the restin domain.

Mutolo MJ, Morris KJ, Leir SH, Caffrey TC, Lewandowska MA, Hollingsworth MA, Harris A.

Matrix Biol. 2012 Jun;31(5):285-9. doi: 10.1016/j.matbio.2012.03.003. Epub 2012 Apr 16.

15.

Molecular mechanisms controlling CFTR gene expression in the airway.

Zhang Z, Ott CJ, Lewandowska MA, Leir SH, Harris A.

J Cell Mol Med. 2012 Jun;16(6):1321-30. doi: 10.1111/j.1582-4934.2011.01439.x.

16.

Structure and function of the perinucleolar compartment in cancer cells.

Slusarczyk A, Kamath R, Wang C, Anchel D, Pollock C, Lewandowska MA, Fitzpatrick T, Bazett-Jones DP, Huang S.

Cold Spring Harb Symp Quant Biol. 2010;75:599-605. doi: 10.1101/sqb.2010.75.026. Epub 2011 Feb 2.

17.

Characterization of MRP RNA-protein interactions within the perinucleolar compartment.

Pollock C, Daily K, Nguyen VT, Wang C, Lewandowska MA, Bensaude O, Huang S.

Mol Biol Cell. 2011 Mar 15;22(6):858-67. doi: 10.1091/mbc.E10-09-0768. Epub 2011 Jan 13.

18.

Deletion of CFTR translation start site reveals functional isoforms of the protein in CF patients.

Ramalho AS, Lewandowska MA, Farinha CM, Mendes F, Gonçalves J, Barreto C, Harris A, Amaral MD.

Cell Physiol Biochem. 2009;24(5-6):335-46. doi: 10.1159/000257426. Epub 2009 Nov 4.

19.

Multiple mechanisms influence regulation of the cystic fibrosis transmembrane conductance regulator gene promoter.

Lewandowska MA, Costa FF, Bischof JM, Williams SH, Soares MB, Harris A.

Am J Respir Cell Mol Biol. 2010 Sep;43(3):334-41. doi: 10.1165/rcmb.2009-0149OC. Epub 2009 Oct 23.

20.

An Alu-derived intronic splicing enhancer facilitates intronic processing and modulates aberrant splicing in ATM.

Pastor T, Talotti G, Lewandowska MA, Pagani F.

Nucleic Acids Res. 2009 Nov;37(21):7258-67. doi: 10.1093/nar/gkp778.

21.

A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome.

Crotti L, Lewandowska MA, Schwartz PJ, Insolia R, Pedrazzini M, Bussani E, Dagradi F, George AL Jr, Pagani F.

Heart Rhythm. 2009 Feb;6(2):212-8. doi: 10.1016/j.hrthm.2008.10.044. Epub 2008 Nov 6.

PMID:
19187913
22.

U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.

Pinotti M, Rizzotto L, Balestra D, Lewandowska MA, Cavallari N, Marchetti G, Bernardi F, Pagani F.

Blood. 2008 Mar 1;111(5):2681-4. Epub 2007 Dec 21.

23.

RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events.

Buratti E, Dhir A, Lewandowska MA, Baralle FE.

Nucleic Acids Res. 2007;35(13):4369-83. Epub 2007 Jun 18.

24.

Functional studies on the ATM intronic splicing processing element.

Lewandowska MA, Stuani C, Parvizpur A, Baralle FE, Pagani F.

Nucleic Acids Res. 2005 Jul 19;33(13):4007-15. Print 2005.

Supplemental Content

Loading ...
Support Center